EL ANUARIO DE ESTADISTICA VITAL DEL MINISTERIO DE SALUD NO SE PUBLICA EN VENEZUELA DESDE EL COMIENZO DEL CUBACHAVISMO HACE 16 AÑOS IMPIDIENDO CONOCER LA MORBIMORTALIDAD DE LOS VENEZOLANOS
Morbidity and Mortality Weekly Report
ND-236
MMWR
/
April 15, 2016
/
V
ol. 65
/
No. 14
Notifiable Diseases and Mortality Tables
See Table I footnotes on next page.
TABLE I. Provisional* cases of selected
†
infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week
ending April 9, 2016 (14th week) (Export data)
Disease
Current
week
Cum
2016
5-year
weekly
average
§
Total cases reported
f
or previous years
States reporting cases
during current week (No.)
2015
2014
2013
2012
2011
Anthrax
—
—
—
—
—
—
—
1
Arboviral diseases
¶,
**
:
Chikungunya virus
††
—
21
1
804
NN
NN
NN
NN
Eastern equine encephalitis virus
—
—
—
6
8
8
15
4
Jamestown Canyon virus
§§
—
—
—
8
11
22
2
3
La Crosse virus
§§
—
—
—
55
80
85
78
130
Powassan virus
—
—
—
7
8
12
7
16
St. Louis encephalitis virus
—
—
0
19
10
1
3
6
Western equine encephalitis virus
—
—
—
—
—
—
—
—
Zika virus
¶¶
1
316
0
42
NN
NN
NN
NN
MD (1)
Botulism, total
2
28
4
189
161
152
168
153
foodborne
—
3
1
37
15
4
27
24
infant
1
23
2
132
127
136
123
97
AR (1)
other (wound and unspecified)
1
2
0
20
19
12
18
32
TX (1)
Brucellosis
1
15
2
119
92
99
114
79
TX (1)
Chancroid
—
2
0
16
—
—
15
8
Cholera
—
—
0
2
5
14
17
40
Cyclosporiasis
**
—
7
1
620
388
784
123
151
Diphtheria
—
—
—
—
1
—
1
—
Haemophilus influenzae
invasive disease (age <5 yrs)***:
serotype b
1
7
1
26
40
31
30
14
AK (1)
non typable serotype
—
49
4
134
128
141
115
93
other serotype
1
65
3
283
266
233
263
230
FL (1)
unknown serotype
1
21
4
40
39
34
37
48
CO (1)
Hansen’s disease
**
—
11
2
85
88
81
82
82
Hantavirus infections
**
:
Hantavirus infection (non-HPS)
††
—
—
—
1
NN
NN
NN
NN
Hantavirus Pulmonary Syndrome (HPS)
—
4
1
17
32
21
30
23
Hemolytic uremic syndrome, postdiarrheal
**
—
31
3
244
250
329
274
290
Hepatitis B, virus infection perinatal
—
7
1
32
47
48
40
NP
Influenza-associated pediatric mortality
**
,
†††
10
44
3
130
141
160
52
118
MA (1), NY (1), NJ (1), OH (1), WI (1), MD (1),
TX (1), CO (1), ME (1), VA (1)
Leptospirosis
**
—
5
0
35
38
NN
NN
NN
Listeriosis
6
98
10
740
769
735
727
870
OH (1), FL (3), WA (2)
Measles
§§§
—
5
4
185
667
187
55
220
Meningococcal disease, invasive
¶¶¶
:
serogroup ACWY
1
25
4
102
123
142
161
257
WA (1)
serogroup B
2
18
3
97
89
99
110
159
TX (2)
other serogroup
—
2
1
22
25
17
20
20
unknown serogroup
1
52
6
156
196
298
260
323
NYC (1)
Novel influenza A virus infections****
—
1
0
6
3
21
313
14
Plague
—
—
0
13
10
4
4
3
Poliomyelitis, paralytic
—
—
—
—
—
1
—
—
Polio virus infection, nonparalytic
**
—
—
—
—
—
—
—
—
Psittacosis
**
—
—
0
6
8
6
2
2
Q fever, total
**
1
13
3
147
168
170
135
134
acute
1
10
2
125
132
137
113
110
AR (1)
chronic
—
3
0
22
36
33
22
24
Rabies, human
—
—
0
1
1
2
1
6
SARS-CoV
—
—
—
—
—
—
—
—
Smallpox
—
—
—
—
—
—
—
—
Streptococcal toxic shock syndrome
**
2
58
6
290
259
224
194
168
ME (1), OH (1)
Syphilis, congenital
††††
—
64
7
450
458
348
322
360
Toxic shock syndrome (staphylococcal)
**
—
5
1
53
59
71
65
78
Trichinellosis
**
—
5
0
10
14
22
18
15
Tularemia
1
10
1
308
180
203
149
166
MO (1)
Typhoid fever
4
64
6
358
349
338
354
390
NY (1), FL (2), WA (1)
Vancomycin-intermediate
Staphylococcus aureus
**
—
27
4
171
212
248
134
82
Vancomycin-resistant
Staphylococcus aureus
**
—
—
—
1
—
—
2
—
Morbidity and Mortality Weekly Report
MMWR
/
April 15, 2016
/
V
ol. 65
/
No. 14
ND
-237
TABLE I. (
Continued
) Provisional* cases of selected
†
infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United
States, week ending April 9, 2016 (14th week) (Export data)
Disease
Current
week
Cum
2016
5-year
weekly
average
§
Total cases reported
f
or previous years
States reporting cases
during current week (No.)
2015
2014
2013
2012
2011
Viral hemorrhagic fevers
§§§§
:
Crimean-Congo hemorrhagic fever
—
—
—
—
NP
NP
NP
NP
Ebola hemorrhagic fever
—
—
—
—
4
NP
NP
NP
Guanarito hemorrhagic fever
—
—
—
—
NP
NP
NP
NP
Junin hemorrhagic fever
—
—
—
—
NP
NP
NP
NP
Lassa fever
—
—
—
—
1
NP
NP
NP
Lujo virus
—
—
—
—
NP
NP
NP
NP
Machupo hemorrhagic fever
—
—
—
—
NP
NP
NP
NP
Marburg fever
—
—
—
—
NP
NP
NP
NP
Sabia-associated hemorrhagic fever
—
—
—
—
NP
NP
NP
NP
Yellow fever
—
—
—
—
—
—
—
—
—: No reported cases.
N: Not r
eportable.
NN: Not Na
tionally Notifiable.
NP
: Nationally notifiable but not published.
C
um: Cumulative year-to-date counts.
*
C
ase counts for reporting years 2015 and 2016 are provisional and subject to change. Data for years 2011 through 2014 are finalized. For further information on interpretation
of these data, see http://wwwn.cdc.gov/nndss/document/ProvisionalNationaNotifiableDiseasesSurveillanceData20100927.pdf
.
†
T
his table does not include cases from the U.S. territories. Three low incidence conditions, rubella, rubella congenital, and tetanus, are in Table II to facilitate case count verifica
-
tion with reporting jurisdictions.
§
C
alculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preced
-
ing years. Additional information is available at http://wwwn.cdc.gov/nndss/document/5yearweeklyaverage.pdf
.
¶
I
ncludes both neuroinvasive and nonneuroinvasive. Updated weekly reports from the Division of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious
Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
*
*
No
t reportable in all reporting jurisdictions. Data from states where the condition is not reportable are excluded from this table, except for the arboviral diseases and influenza-associated
pediatric mortality. Reporting exceptions are available at http://wwwn.cdc.gov/nndss/downloads.html
.
††
Da
ta for Chikungunya virus and Hantavirus infection, non-HPS. Office of Management and Budget approval of the NNDSS Revision #0920-0728 on January 21, 2016, authorized
CDC to receive data for these conditions. CDC is in the process of soliciting data for these conditions
§§
Jamestown Canyon virus and Lacrosse virus have replaced California serogroup diseases.
¶¶
T
his table does not include cases from the U.S. territories. There may be some delay between identification of a case and reporting to CDC. All cases reported are travel related.
Office of Management and Budget approval of the NNDSS Revision #0920-0728 on January 21, 2016, authorized CDC to receive data for these conditions. CDC is in the process
of soliciting data for these conditions.
***
Da
ta for
H. influenzae
(all ages, all serotypes) are available in Table II.
†††
Upda
ted weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since October 4, 2015, 50 influenza-associated pediatric deaths
occurring during the 2015-16 influenza season have been reported.
§§§
No measles cases w
ere reported for the current week.
¶¶¶
Da
ta for meningococcal disease (all serogroups) are available in Table II.
****
A
ll cases of novel influenza A virus infection reported to CDC since 2011 have been variant viruses. Influenza viruses that circulate in swine are called swine influenza viruses when
isolated from swine, but are called variant viruses when isolated from humans. Variant influenza viruses are different from the influenza A (H1N1)pdm09 virus. Total case counts
are provided by the Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD).
††††
Upda
ted weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
§§§§
Prior to 2015, CDC’s National Notifiable Diseases Surveillance System (NNDSS) did not receive electronic data about incident cases of specific viral hemorrhagic fevers; instead
data were collected in aggregate as “viral hemorrhagic fevers”. Beginning in 2015, NNDSS has been updated to receive data for each of the viral hemorrhagic fevers listed
below. In addition to the four cases of Ebola diagnosed in the United States to date in 2014, six residents of the United States have been medically evacuated to the United
States for care after developing Ebola in West Africa. Ten of the 11 Viral Hemorrhagic Fever cases reported for 2014 are confirmed as Ebola and one as Lassa fever.
